⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
globenewswire.com
MRK
PFE
GSK
GILD
Menlo Ventures Raises $3B for AI as Silicon Valley VC Marks 50 Years
globenewswire.com
GOOG
MSFT
AMZN
NVDA
META
ROKU
UBER
GILD
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
globenewswire.com
NVDA
LRCX
AMAT
SNOW
CDNS
MRVL
MU
SMCI
AMD
INTC
QCOM
GOOG
MSFT
AMZN
LLY
NTRS
REGN
GILD
BMY
PFE
MRNA
BIIB
VRTX
CRSP
EXAS
ROST
DSY
TMO
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX
European Commission Approves Trodelvy ® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
businesswire.com
GILD
European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
businesswire.com
GILD
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
globenewswire.com
BIIB
AMGN
BMY
IMVT
AZN
MRK
CTNT
REGN
GILD
NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
accessnewswire.com
NNVC
GILD
SIGA
EBS
F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis
globenewswire.com
GILD
Hearst Magazines Hosts 2nd Annual Men's Health Lab in Partnership With NYU Langone Health
prnewswire.com
BG
GILD